Chenming Qiu
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Bulk and single-cell transcriptomics for identification of potential diagnostic biomarkers associated with pulmonary arterial hypertension and integrated stress response and experimental validation.
Journal: Clinical and experimental hypertension (New York, N.Y. : 1993)
Published: February 18, 2026
DDX17 deficiency inhibits the proliferation and migration of vascular smooth muscle cells by inhibiting RHEB/mTORC1-mediated glycolysis and oxidative stress.
Journal: Journal of hypertension
Published: October 08, 2024
Inhibition of CIRBP represses the proliferation and migration of vascular smooth muscle cells via inhibiting Rheb/mTORC1 axis.
Journal: Biochemical and biophysical research communications
Published: May 29, 2024
Inhibition of DYRK1A attenuates vascular remodeling in pulmonary arterial hypertension via suppressing STAT3/Pim-1/NFAT pathway.
Journal: Clinical and experimental hypertension (New York, N.Y. : 1993)
Published: December 26, 2023
Forsythoside B Mitigates Monocrotaline-Induced Pulmonary Arterial Hypertension via Blocking the NF-κB Signaling Pathway to Attenuate Vascular Remodeling.
Journal: Drug design, development and therapy
Published: November 14, 2023
RGS10 inhibits proliferation and migration of pulmonary arterial smooth muscle cell in pulmonary hypertension via AKT/mTORC1 signaling.
Journal: Clinical and experimental hypertension (New York, N.Y. : 1993)
Published: October 25, 2023
Galangin attenuates doxorubicin-induced cardiotoxicity via activating nuclear factor erythroid 2-related factor 2/heme oxygenase 1 signaling pathway to suppress oxidative stress and inflammation.
Journal: Phytotherapy research : PTR
Published: May 26, 2023
Role of Nuclear Receptor Subfamily 1 Group D Member 1 in the Proliferation, Migration of Vascular Smooth Muscle Cell, and Vascular Intimal Hyperplasia.
Journal: Journal of cardiovascular pharmacology
Published: March 22, 2023
Amentoflavone mitigates doxorubicin-induced cardiotoxicity by suppressing cardiomyocyte pyroptosis and inflammation through inhibition of the STING/NLRP3 signalling pathway.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: February 04, 2023
Rosmarinic acid protects against lipopolysaccharide-induced cardiac dysfunction via activating Sirt1/PGC-1α pathway to alleviate mitochondrial impairment.
Journal: Clinical and experimental pharmacology & physiology
Published: July 06, 2022
RAS protein activator like 2 promotes the proliferation and migration of pulmonary artery smooth muscle cell through AKT/mammalian target of Rapamycin complex 1 pathway in pulmonary hypertension.
Journal: Bioengineered
Published: January 19, 2022
Inhibition of GPR35 Preserves Mitochondrial Function After Myocardial Infarction by Targeting Calpain 1/2.
Journal: Journal of cardiovascular pharmacology
Published: March 21, 2020
Last Updated: 09/26/2026